Skip to content
  • Join Our Team
  • News & Events
    • Press Releases
    • Latest News
    • Events
  • Investors
Group 167 (1)
  • Platforms
  • Our Approach
    • Our Technology
    • Technical & Regulatory Support
    • Partnerships
    • Collaboration
  • Who We Serve
    • Cell & Gene Therapy
    • Discovery & Translational Research
    • Bioprocessing
  • Learning Hub
    • Applications
    • Featured Science
    • Resource Library
    • Scientific Publications
    • Webinars & Presentations
    • What Cells Can I Use?
  • About Us
    • Our History
    • Our Team
    • Board of Directors
    • Join our Team
  • Contact Us
    • Ask the ExPERT
    • Request a Quote
    • Technical Support
Menu
Mobile logo
  • Platforms
    • Electroporation Systems
  • Our Approach
    • Our Technology
    • Technical & Regulatory Support
    • Partnerships
    • Collaboration
  • Who We Serve
    • Cell & Gene Therapy
    • Discovery
    • Bioprocessing & Protein Production
  • Learning Hub
    • Applications
    • Featured Science
    • Resource Library
    • Scientific Publications
    • Webinars & Presentations
    • What cells can I use?
  • About Us
    • Our History
    • Our Team
    • Board of Directors
    • Join our Team
  • Join Our Team
  • News & Events
    • Press Releases
    • Latest News
    • Events
  • Investors
  • Contact Us
    • Ask the ExPERT
    • Request a Quote
    • Technical Support

MaxCyte Minutes Newsletter – Q3 2022

At MaxCyte®, we know that cells are precious. Especially when they are the key to novel treatments for patients in need. In this issue of the MaxCyte Minutes newsletter, we share some featured news, events, and technical content to show how we can help you with your next cell engineering project and expedite your research from concept to clinic and commercialization.

IN THE NEWS

Maxcyte-LGChem

MaxCyte to support LG Chem CAR T programs

MaxCyte is thrilled to announce that we are partnering with LG Chem to support their CAR T programs for solid tumors. This partnership represents our first strategic platform license (SPL) with a South Korean company and broadens our reach into Asia. This collaboration enables us to provide advanced technologies that support the clinical and commercial development of engineered cell therapies that can treat cancer patients across the globe.

View More
News image

Exploring Flow Electroporation® for Cell Engineering

Our Chief Scientific Officer, Dr. Cenk Sumen, recently spoke with Technology Networks about the numerous applications of cell engineering and how Flow Electroporation® technology can support cell engineering from small- to large-scale.

View More

CELL & GENE THERAPY

Upcoming Webinar. Beyond affinity: antibody discovery, optimization, and developability screening from mammalian display libraries

Join us for a Lab roots Webinar and learn about detecting and avoiding antibodies with problematic developability profiles during early discovery. You can also find out about IONTAS’ novel technology for displaying antibodies on the surface of mammalian cells for antibody screening.

Date: Wednesday, October 19, 2022
Time:: 6:00am (PDT), 8:00am (EDT), 9:00am (CEST)

REGISTER NOW
cell-therapy-labroot

Featured Presentation: Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology

At this year’s ASGCT (American Society of Gene and Cell Therapy) annual meeting, we were honored to have two of our clients, Dr. Jonathan Yen and Dr. Alicja Copik, present. They discussed how MaxCyte helped them unlock the full potential of their research by solving development and commercialization challenges.

DOWNLOAD PRESENTATION
acst-logo@2x

Poster: In Vitro Characterization of CD19 CAR T Cells Derived

We also presented a poster at ASGCT! Here, MaxCyte electroporation was used to engineer T cells with mRNA. CAR T cells efficiently targeted and killed CD19-expressing cancer cells. If you missed the poster presentation, it’s available to download on our website.

DOWNLOAD POSTER
CAR_Tcell

BIOPROCESSING

Cenk-Sumen

Transient Protein Expression Will Revolutionize Bioproduction

Our Chief Scientific Officer, Dr. Cenk Sumen, recently contributed to a Genetic Engineering & Biotechnology News article offering insights into transient protein expression and its ability to transform bioproduction.

READ ARTICLE

FOCUS ON

cell-theropy-focus-img

Rick Urbanski, Manufacturing Engineer

For this issue, we spent time with Rick Urbanski, from the Manufacturing Engineering team at MaxCyte. He designs and builds tooling to support manufacturing operations throughout the MaxCyte product portfolio. Let’s meet Rick!

READ MORE

MEET US

emily-logo@2x

September 17, 2022; 6:00 pm - 10:00 pm
Valley Forge Casino Resort King of Prussia, PA

Emily Whitehead Foundation - Believe Ball

VIEW ALL EVENTS
BioProcess-International

September 27 - September 30
Boston, MA

Biotech Week Boston

Group 167 (1)
Receive upcoming events, new resources and more in your inbox
Sign Me up to the Newsletter

Platforms

Platforms
  • Electroporation Systems
  • Processing Assemblies
  • Reagents & Accessories

Who We Serve

Who We Serve
  • Cell & Gene Therapy
  • Bioprocessing
  • Discovery & Translational Research

Our Approach

Our Approach
  • Our Technology
  • Technical & Regulatory Support
  • Partnerships
  • Collaboration

About Us

About Us
  • About MaxCyte
  • Our History
  • Our Team
  • Board of Directors
  • Join our Team

Investors

Distributors

Follow Us

Ask the ExPERT

Request a Quote

Technical Support

© 2023 MaxCyte. All Rights Reserved.

  • Quality Systems
  • Privacy Policy
  • Terms and Conditions
  • Legal Disclaimer

Electroporation Systems

ATx_03_shadow-132@2x

ATx

From small to medium static Electroporation.

STx_04_shadow@2x

STx

Transfect up to 20 billion cells with scalable static or flow-through electroporation.

GTx_05_shadows@2x

GTx

Transfect up to 20 billion cells with our clinically validated and cGMP compliant flow-through electroporation.

VLX-right-132@2x

VLx

For gram scale protein production.

Consumables

PA-Top-Image@2x

Processing Assemblies

Achieve the desired scale and throughput with a range of consumable devices.

hyclone-bottle-small@2x

Reagents & Supporting Products

Complement your workflow with our flexible electroporation buffer formats and accessories.